G Medical Innovations Holdings Limited - Warrants (30/06/2025) EBIT

G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s ebit stands at $-2.7M as of June 2022. That compares with $-12M in the prior-year period — up 76.4% year over year. That is below the Healthcare sector average of $1.9T. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

G Medical Innovations Holdings Limited - Warrants (30/06/2025) reported $-2.7M in EBIT versus $-12M a year earlier — a 76.4% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

G Medical Innovations Holdings Limited - Warrants (30/06/2025) sits lower the Healthcare benchmark ($1.9T) with a EBIT of $-2.7M. That is roughly 100.0% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

That compares with $-12M in the prior-year period — up 76.4% year over year. Sustained growth in EBIT can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how G Medical Innovations Holdings Limited - Warrants (30/06/2025)'s EBIT evolved across reporting periods, while the comparison chart places GMVDW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.